Women and Heart Disease

Clinical Trial Finder

Many women with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Effect of Polyvitaminics (Pyridoxine Hydrochloride, Folic Acid and Cyanocobalamin) in the Concentration of Homocysteine and Lipid Profile in Postmenopausal Women: a Randomized Controlled, Double-blind Clinical Trial

Conditions:   Menopause;   Dyslipidemias;   Homocystinaemia
Interventions:   Drug: Tenavit®;   Drug: Placebo Oral Tablet
Sponsor:   Casa de Saúde santa Marcelina
Completed - verified July 2017

Carb Quality and CHD in US Adults

Condition:   Coronary Heart Disease
Intervention:   Other: Carbohydrate quality
Sponsors:   Harvard School of Public Health;   Kuwait Foundation for the Advancement of Science;   National Cancer Institute (NCI);   National Heart, Lung, and Blood Institute (NHLBI);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed - verified July 2017

Coronary Anatomy Study and Times Since the Onset of Acute Myocardial Infarction Symptoms in Women Until the Opening of the Artery (TAPAC Study)

Condition:   Myocardial Infarction
Intervention:   Other: Non intervention
Sponsor:   Hospital Universitari Vall d'Hebron Research Institute
Not yet recruiting - verified April 2017

Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Subjects

Condition:   Non-obstructive Coronary Artery Disease
Interventions:   Drug: Nicorandil;   Drug: Standard treatment
Sponsor:   Merck KGaA
Recruiting - verified July 2017

Evaluation to Assess Cognitive Training for the Prevention of Post-operative Cognitive Decline

Condition:   Cognitive Dysfunction
Intervention:   Behavioral: Cognitive training program RehaCom®
Sponsor:   Charite University, Berlin, Germany
Recruiting - verified July 2017

Perioperative Assessment of Right Ventricular Function and Venous Return in Patients With Epithelial Ovarian Cancer Undergoing Cytoreductive Surgery (Gyn Right) - Pilot Study

Condition:   Right Ventricular Function and Venous Return
Intervention:  
Sponsor:   Charite University, Berlin, Germany
Withdrawn - verified July 2017

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

Conditions:   Stroke;   Secondary Prevention
Interventions:   Drug: optional ASA as comedication;   Drug: placebo to ASA;   Drug: placebo to optional ASA as comedication;   Drug: placebo to dabigatran etexilate;   Drug: ASA 100 mg;   Drug: dabigatran etexilate
Sponsor:   Boehringer Ingelheim
Recruiting - verified July 2017

Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"

Condition:   Coronary Artery Disease
Interventions:   Device: Medtronic Endeavor Coronary Stent System;   Device: DESyne BD Novolimus Stent System;   Device: DESyne Novolimus Stent System
Sponsor:   Elixir Medical Corporation
Completed - verified July 2017

Genetic Markers of CHD Risk in Men and Women

Conditions:   Cardiovascular Diseases;   Coronary Disease;   Heart Diseases;   Myocardial Infarction;   Inflammation
Intervention:  
Sponsors:   State University of New York at Buffalo;   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified July 2008